India · Delayed Price · Currency is INR Eris Lifesciences Statistics
Total Valuation
BOM:540596 has a market cap or net worth of INR 187.72 billion. The enterprise value is 210.56 billion.
| Market Cap | 187.72B |
| Enterprise Value | 210.56B |
Important Dates
The last earnings date was Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
| Current Share Class | 138.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.84% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 59.48% |
| Owned by Institutions (%) | 21.85% |
| Float | 44.19M |
Valuation Ratios
The trailing PE ratio is 29.15 and the forward PE ratio is 28.78.
| PE Ratio | 29.15 |
| Forward PE | 28.78 |
| PS Ratio | 5.84 |
| PB Ratio | 4.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 77.85 |
| P/OCF Ratio | 34.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.61, with an EV/FCF ratio of 87.32.
| EV / Earnings | 32.70 |
| EV / Sales | 6.55 |
| EV / EBITDA | 18.61 |
| EV / EBIT | 24.56 |
| EV / FCF | 87.32 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 2.08 |
| Debt / FCF | 9.78 |
| Interest Coverage | 4.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.88% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.58M |
| Profits Per Employee | 1.92M |
| Employee Count | 3,354 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -88.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -24.26% |
| 50-Day Moving Average | 1,410.83 |
| 200-Day Moving Average | 1,448.58 |
| Relative Strength Index (RSI) | 37.80 |
| Average Volume (20 Days) | 12,603 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:540596 had revenue of INR 32.12 billion and earned 6.44 billion in profits. Earnings per share was 46.85.
| Revenue | 32.12B |
| Gross Profit | 23.62B |
| Operating Income | 8.59B |
| Pretax Income | 6.57B |
| Net Income | 6.44B |
| EBITDA | 11.32B |
| EBIT | 8.59B |
| Earnings Per Share (EPS) | 46.85 |
Balance Sheet
The company has 673.00 million in cash and 23.59 billion in debt, with a net cash position of -22.91 billion.
| Cash & Cash Equivalents | 673.00M |
| Total Debt | 23.59B |
| Net Cash | -22.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 38.96B |
| Book Value Per Share | 285.48 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 5.38 billion and capital expenditures -2.97 billion, giving a free cash flow of 2.41 billion.
| Operating Cash Flow | 5.38B |
| Capital Expenditures | -2.97B |
| Depreciation & Amortization | 2.74B |
| Net Borrowing | -1.25B |
| Free Cash Flow | 2.41B |
| FCF Per Share | n/a |
Margins
Gross margin is 73.53%, with operating and profit margins of 26.73% and 20.05%.
| Gross Margin | 73.53% |
| Operating Margin | 26.73% |
| Pretax Margin | 20.45% |
| Profit Margin | 20.05% |
| EBITDA Margin | 35.25% |
| EBIT Margin | 26.73% |
| FCF Margin | 7.74% |
Dividends & Yields
This stock pays an annual dividend of 7.21, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | 7.21 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.84% |
| Shareholder Yield | -0.31% |
| Earnings Yield | 3.43% |
| FCF Yield | 1.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:540596 is 1,661.20, which is 22.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,661.20 |
| Price Target Difference | 22.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 13.46% |
| EPS Growth Forecast (3Y) | 13.71% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |